Type 1 Diabetes study: Aerobic Exercise vs Resistance Exercise
Official title Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
ClinicalTrials.gov ID: NCT05188027
What this study is testing
- What it's testing
- The study wants to see how blood glucose changes during and after moderate exercise compared to a resting period.
- Who it's for
- Post‑menopausal women who have type 1 diabetes.
- What's involved
- Participants will wear a continuous glucose monitor for at least three days on three separate occasions: a 90‑minute rest session, a 30‑minute moderate aerobic workout with 60 minutes of recovery, and a 30‑minute moderate weight‑lifting workout with 60 minutes of recovery. Blood samples will be taken during and after exercise to measure glucose levels.
- Time commitment
- The study lasts about three days of monitoring on each of the three occasions, with each session lasting roughly 2.5 hours.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75, women only
You may be able to join if
- type 1 diabetes, diagnosed for at least one year
- post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
- able to perform aerobic and resistance exercise
- able to visit the lab in Edmonton, Alberta (University of Alberta)
You likely can't join if
- HbA1c \> 9.9 %
- frequent and unpredictable hypoglycemia
- change in insulin management strategy within the last 2 months
- blood pressure \> 140 / 95
- severe peripheral neuropathy
- history of cardiovascular disease
See the full eligibility criteria
- type 1 diabetes, diagnosed for at least one year
- post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
- able to perform aerobic and resistance exercise
- able to visit the lab in Edmonton, Alberta (University of Alberta)
- HbA1c \> 9.9 %
- frequent and unpredictable hypoglycemia
- change in insulin management strategy within the last 2 months
- blood pressure \> 140 / 95
- severe peripheral neuropathy
- history of cardiovascular disease
- musculoskeletal injuries interfering with exercise performance
- use of medications (other than insulin) that affect glucose metabolism
- BMI \> 30 kg/m2
- smoking
- moderate to high alcohol intake (\> 2 drinks/day)
The study team makes the final eligibility decision.
Where it is enrolling
- Edmonton, Alberta, Canada
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Edmonton, Alberta, Canada; Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.